Tamoxifen: transition from the laboratory to clinical preventive chemosuppression.
Tormey
D C
DC
University of Wisconsin Clinical Cancer Center, Madison, Wisconsin.
D001943:Breast Neoplasms / Q000517:prevention & control*; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D008593:Menopause; D010024:Osteoporosis / Q000139:chemically induced; D013629:Tamoxifen / Q000009:adverse effects* / Q000097:blood; D013927:Thrombosis / Q000139:chemically induced
D004967:Estrogens; D013629:Tamoxifen